Within gastric cancer cells and mouse models, LIF has been seen to be downregulated, and the addition of recombinant LIF or genetic LIF upregulation inhibits proliferation and tumor progression by downregulating cyclin D1, thereby inducing G1 phase arrest [103]. The gene discussed is LIF; the disease is gastric cancer.